Financhill
Back

Cybin 10K Form

Buy
51

CYBN
Cybin

Last Price:
9.68
Seasonality Move:
25.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CYBN News And Ratings

See the #1 stock for the next 7 days that we like better than CYBN

CYBN Financial Statistics

Sales & Book Value

Annual Sales: $654.08K
Cash Flow: $-19.25M
Price / Cash Flow: 0
Annual Sales: $9.44
Price / Book: 1.04

Profitability

EPS (TTM): -5.95450
Net Income (TTM): $-90.85M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Cybin Earnings Forecast

Key Cybin Financial Ratios

  • The Selling, General & Administrative Expenses for CYBN have been equal to 3,069.09% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 4 years have been positive in 2 years.

Cybin Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CYBN
Website: cybin.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CYBN Technical Analysis vs Fundamental Analysis

Buy
51
Cybin (CYBN) is a Buy

Is Cybin a Buy or a Sell?

  • Cybin stock is rated a Buy
    The current Cybin [CYBN] share price is $9.82. The Score for CYBN is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.